Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics
Recruiting
- Conditions
- Non Small Cell Lung CancerHealthy
- Interventions
- Other: blood, stool and tissue samples collection
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- OncoHost Ltd.
- Target Recruit Count
- 350
- Registration Number
- NCT05736029
- Locations
- ๐บ๐ธ
Baylor Scott and White Research Institute, Dallas, Texas, United States
Predicting Response Patterns to Treatment in Glioblastoma (GBM) Patients
Suspended
- Conditions
- Glioblastoma
- First Posted Date
- 2020-01-07
- Last Posted Date
- 2022-04-19
- Lead Sponsor
- OncoHost Ltd.
- Target Recruit Count
- 1000
- Registration Number
- NCT04219475
- Locations
- ๐ฎ๐ฑ
Rambam medical center, Haifa, Israel
๐ฎ๐ฑRabin medical center, Petah tikva, Israel
๐ฎ๐ฑSourasky medical center, Tel Aviv, Israel
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
Recruiting
- Conditions
- Stage IV Non-small Cell Lung CancerStage IV Malignant MelanomaStage IV Small Cell Lung CancerStage III Malignant Melanoma
- Interventions
- Other: Plasma sample collection
- First Posted Date
- 2019-08-14
- Last Posted Date
- 2023-08-29
- Lead Sponsor
- OncoHost Ltd.
- Target Recruit Count
- 2000
- Registration Number
- NCT04056247
- Locations
- ๐ฎ๐ฑ
Shamir Medical Center, Be'er Ya'aqov, Israel
๐ฎ๐ฑRambam Medical Center, Haifa, Israel
๐ฎ๐ฑMeir medical center, Kfar Saba, Israel
ยฉ Copyright 2025. All Rights Reserved by MedPath